Ardent Health (ARDT)
NYSE Market Open
Ardent Health, Inc. is a US healthcare provider focused on mid-sized urban communities where regional hospital systems play an important role in local access to care. The company operates across selected markets in Texas, Oklahoma, New Mexico, New Jersey, Idaho and Kansas, providing acute care and related healthcare services through hospitals, outpatient facilities and physician networks.
Ardent’s model centres on building integrated regional systems rather than operating stand-alone hospitals in isolation. Its facilities typically combine emergency care, surgical services, inpatient treatment, diagnostic imaging, specialty medicine, primary care and outpatient services. This structure allows the company to serve patients across multiple stages of care, from routine consultations to higher-acuity hospital treatment.
The company places emphasis on investment in people, clinical services and technology. In practical terms, that means recruiting and retaining healthcare professionals, expanding service lines in growing communities, and using digital tools, data systems and modern clinical infrastructure to improve patient access and operational efficiency. Like other hospital operators, Ardent works within a complex reimbursement environment that includes commercial insurers, Medicare, Medicaid and self-pay patients.
Ardent Health is distinctive because it targets markets that are large enough to support advanced medical services but are often less saturated than major metropolitan healthcare hubs. Its strategy depends on deep local presence, partnerships with physicians, and the ability to allocate capital toward facilities and services that meet community demand. For investors, the company represents exposure to regional healthcare delivery in the United States, with performance tied to patient volumes, payer mix, labour costs and healthcare spending trends.
Last updated
- Market Cap
- 1.23B
- P/E
- 9.18
- P/FCF
- 5.66
- P/S
- 0.19
- Enterprise Value
- 1.73B
- Sector
- Health Care
- Industry
- General Medical and Surgical Hospitals
- Address
- 340 SEVEN SPRINGS WAY, BRENTWOOD, TN, 37027
ARDENT HEALTH FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
EDR IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 18 Deadline in Securities Class Action - EDR
BRBR IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BellRing Brands, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BRBR
ARDT FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardent Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT
$ARDT Class Reminder: Ardent Health Investors Reminded of the Monday March 9 Securities Class Action Deadline – Investors with Losses Urged to Contact BFA Law
$DRVN Investigation News: Driven Brands Investors Notified of the Ongoing Securities Investigation – Investors with Losses Urged to Contact BFA Law
Investors who lost money on Ardent Health, Inc. (ARDT) should contact The Gross Law Firm about pending Class Action - ARDT
ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
ARDENT HEALTH URGENT DEADLINE: Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights
ARDT IMPORTANT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
ARDT Deadline: BFA Law Urges Ardent Health Investors with Losses to Act Before March 9 Securities Fraud Class Action Deadline Amid 33% Stock Decline
Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. - ARDT
Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
ARDENT HEALTH CLASS ACTION: Bragar Eagel & Squire, P.C. Reminds Ardent Health, Inc. Stockholders to Contact the Firm Before March 9th Regarding Their Rights
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT
ARDT 2-WEEK DEADLINE ALERT: Ardent Health Facing Securities Class Action Over Alleged $97M Accounting Shock and “180-Day Cliff” Reserves – Hagens Berman
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.23B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.73B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 9.18
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.92
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.19
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 3.41
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.27
- EPS
- 0.94
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 5.66
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 2.83
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 217.99M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 10.04%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 2.56%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.83
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.12
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.64
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 504.9K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 8.6
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.6B | 1.61B | 1.58B | 1.65B | 1.5B |
| Gross profit | 1.6B | 1.61B | 1.58B | 1.65B | 1.5B |
| Operating income | 86.8M | 104.75M | 16.46M | 137.28M | 88.37M |
| EBITDA | 129.79M | 145.79M | 55.61M | 176.59M | 124.58M |
| Net income | 39.85M | 44.96M | -23.48M | 72.95M | 41.38M |
| Basic EPS | 0.28 | 0.31 | -0.17 | 0.52 | 0.3 |
| Diluted EPS | 0.28 | 0.32 | -0.17 | 0.52 | 0.29 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 5.25B | 5.29B | 5.15B | 5.03B | 4.91B |
| Total liabilities | 3.52B | 3.61B | 3.52B | 3.38B | 3.35B |
| Total equity | 1.73B | 1.69B | 1.63B | 1.65B | 1.56B |
| Cash & equivalents | 609.69M | 709.6M | 609.44M | 540.63M | 495.04M |
| Current assets | 2.02B | 2.06B | 1.96B | 1.88B | 1.76B |
| Current liabilities | 951.48M | 1.05B | 943.15M | 880.87M | 830.14M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -60.22M | 223.44M | 154.37M | 117.49M | -24.79M |
| Investing cash flow | -27.9M | -86.23M | -58.63M | -46.25M | -23.12M |
| Financing cash flow | -11.79M | -37.05M | -26.93M | -25.66M | -13.83M |
| Change in cash | -99.91M | 100.16M | 68.81M | 45.59M | -61.74M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — Ardent Health, Inc. | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Ardent Health, Inc. | View Filing | |
| edgar index | DEFA14A — Ardent Health, Inc. | View Filing | |
| edgar index | ARS — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| form 4 | Form 4 — Bonick Martin | View Filing | |
| form 4 | Form 4 — Bonick Martin | View Filing | |
| form 4 | Form 4 — LUMSDAINE ALFRED | View Filing | |
| form 4 | Form 4 — LUMSDAINE ALFRED | View Filing | |
| form 4 | Form 4 — Byers David Raynor | View Filing | |
| form 4 | Form 4 — Byers David Raynor | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Caspers Dave | View Filing | |
| form 4 | Form 4 — Caspers Dave | View Filing | |
| form 4 | Form 4 — BYNOE PETER C B | View Filing | |
| form 4 | Form 4 — Campion Suzanne | View Filing | |
| form 4 | Form 4 — GOODYEAR WILLIAM M | View Filing | |
| form 4 | Form 4 — DeMichiei Robert | View Filing | |
| form 4 | Form 4 — Robinson Edmondo | View Filing | |
| form 4 | Form 4 — Webb Robert Thomas | View Filing | |
| form 4 | Form 4 — Sen Rahul | View Filing | |
| form 4 | Form 4 — Sotir Mark R | View Filing | |
| form 4 | Form 4 — Havdala Ellen | View Filing | |
| form 4 | Form 4 — Bulgarelli Peter J. | View Filing | |
| form 4 | Form 4 — Bonick Martin | View Filing | |
| form 4 | Form 4 — LUMSDAINE ALFRED | View Filing | |
| form 4 | Form 4 — Byers David Raynor | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — Ardent Health, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| edgar index | 4 — Ardent Health, Inc. | View Filing | |
| form 4 | Form 4 — Byers David Raynor | View Filing | |
| form 4 | Form 4 — Bonick Martin | View Filing | |
| form 4 | Form 4 — Chernin Ethan | View Filing | |
| form 4 | Form 4 — LUMSDAINE ALFRED | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| form 4 | Form 4 — Petrovich Stephen C. | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-Q — Ardent Health, Inc. | View Filing | |
| edgar index | 8-K — Ardent Health, Inc. | View Filing |